Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea
· Delayed Price · Currency is KRW
3,730.00
-140.00 (-3.62%)
Apr 28, 2025, 2:39 PM KST
Xcell Therapeutics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Apr '25 Apr 25, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 42,332 | 44,384 | - | - | - | - | |
| Enterprise Value | 39,232 | 38,298 | - | - | - | - | |
| Last Close Price | 3870.00 | 4065.00 | - | - | - | - | |
| PS Ratio | 21.88 | 22.95 | - | - | - | - | |
| PB Ratio | 4.64 | 4.87 | - | - | - | - | |
| P/TBV Ratio | 4.93 | 5.17 | - | - | - | - | |
| EV/Sales Ratio | 20.28 | 19.80 | - | - | - | - | |
| Debt / Equity Ratio | 0.63 | 0.63 | 2.73 | 0.69 | 0.38 | 3.54 | |
| Asset Turnover | 0.14 | 0.14 | 0.09 | 0.05 | 0.10 | 0.05 | |
| Inventory Turnover | 4.44 | 4.44 | 4.01 | 4.67 | 3.87 | 2.48 | |
| Quick Ratio | 1.90 | 1.90 | 0.36 | 1.19 | 2.83 | 1.18 | |
| Current Ratio | 2.14 | 2.14 | 0.52 | 1.39 | 2.93 | 1.29 | |
| Return on Equity (ROE) | -165.90% | -165.90% | -170.80% | -67.53% | -102.65% | - | |
| Return on Assets (ROA) | -42.63% | -42.63% | -43.01% | -26.46% | -18.88% | -26.46% | |
| Return on Capital (ROIC) | -49.18% | -49.18% | -48.12% | -28.23% | -24.84% | -108.77% | |
| Earnings Yield | -22.54% | -21.50% | - | - | - | - | |
| FCF Yield | -17.43% | -16.63% | - | - | - | - | |
| Buyback Yield / Dilution | -13.14% | -13.14% | -1.02% | -5.71% | -131.08% | -107.45% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.